Tiansheng Pharmaceutical Group Co Ltd Asset Resilience Ratio
Tiansheng Pharmaceutical Group Co Ltd asset resilience ratio. Tiansheng Pharmaceutical Group Co Ltd (002872) has an Asset Resilience Ratio of -3.12% as of December 2023. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See 002872 defensive interval ratio to measure how many days the company can operate on defensive assets alone.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio of Tiansheng Pharmaceutical Group Co Ltd (2012–2023)
Asset resilience ratio of Tiansheng Pharmaceutical Group Co Ltd from 2012 to 2023. This chart shows how Tiansheng Pharmaceutical Group Co Ltd's Asset Resilience Ratio has changed over time. Read 002872 total liabilities for a breakdown of total debt and financial obligations.
Liquid Assets Composition Over Time
This chart breaks down Tiansheng Pharmaceutical Group Co Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see Tiansheng Pharmaceutical Group Co Ltd balance sheet assets.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CN¥0.00 | 0% |
| Short-term Investments | CN¥-87.67 Million | -3.12% |
| Total Liquid Assets | CN¥-87.67 Million | -3.12% |
Asset Resilience Insights
- Limited Liquidity: Tiansheng Pharmaceutical Group Co Ltd maintains only -3.12% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company primarily holds liquidity in cash and equivalents rather than short-term investments.
Tiansheng Pharmaceutical Group Co Ltd Industry Peers by Asset Resilience Ratio
Compare Tiansheng Pharmaceutical Group Co Ltd's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Madrigal Pharmaceuticals Inc
NASDAQ:MDGL |
Biotechnology | 62.31% |
|
Verona Pharma plc
F:I9SA |
Biotechnology | 0.00% |
|
Centessa Pharmaceuticals PLC ADR
NASDAQ:CNTA |
Biotechnology | 33.37% |
|
Shanghai RAAS Blood Products Co Ltd Class A
SHE:002252 |
Biotechnology | 2.03% |
|
Beijing Tiantan Biological Products Corp Ltd
SHG:600161 |
Biotechnology | 8.08% |
|
Bavarian Nordic
CO:BAVA |
Biotechnology | 10.83% |
|
Hebei Changshan Biochem Pharma
SHE:300255 |
Biotechnology | -0.03% |
|
Tibet Cheezheng Tibetan Medicine Co Ltd
SHE:002287 |
Biotechnology | 37.31% |
Tiansheng Pharmaceutical Group Co Ltd Asset Resilience Ratio by Year (2012–2023)
Tiansheng Pharmaceutical Group Co Ltd asset resilience ratio by year from 2012 to 2023. The table below shows the annual Asset Resilience Ratio data for Tiansheng Pharmaceutical Group Co Ltd.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2023-12-31 | -3.12% | CN¥-87.67 Million ≈ $-12.83 Million |
CN¥2.81 Billion ≈ $411.32 Million |
-0.82pp |
| 2022-12-31 | -2.30% | CN¥-68.30 Million ≈ $-9.99 Million |
CN¥2.97 Billion ≈ $434.58 Million |
-4.93pp |
| 2021-12-31 | 2.63% | CN¥82.00 Million ≈ $12.00 Million |
CN¥3.12 Billion ≈ $456.56 Million |
+4.07pp |
| 2020-12-31 | -1.45% | CN¥-52.69 Million ≈ $-7.71 Million |
CN¥3.65 Billion ≈ $533.52 Million |
-0.19pp |
| 2019-12-31 | -1.26% | CN¥-55.16 Million ≈ $-8.07 Million |
CN¥4.39 Billion ≈ $642.61 Million |
-1.45pp |
| 2018-12-31 | 0.19% | CN¥8.96 Million ≈ $1.31 Million |
CN¥4.67 Billion ≈ $683.93 Million |
+1.28pp |
| 2016-12-31 | -1.09% | CN¥-37.04 Million ≈ $-5.42 Million |
CN¥3.39 Billion ≈ $496.35 Million |
+0.36pp |
| 2015-12-31 | -1.45% | CN¥-41.56 Million ≈ $-6.08 Million |
CN¥2.87 Billion ≈ $419.40 Million |
-0.66pp |
| 2014-12-31 | -0.79% | CN¥-19.60 Million ≈ $-2.87 Million |
CN¥2.50 Billion ≈ $365.12 Million |
-0.38pp |
| 2013-12-31 | -0.41% | CN¥-8.82 Million ≈ $-1.29 Million |
CN¥2.16 Billion ≈ $315.92 Million |
-0.08pp |
| 2012-12-31 | -0.33% | CN¥-5.70 Million ≈ $-834.25K |
CN¥1.74 Billion ≈ $255.19 Million |
-- |
About Tiansheng Pharmaceutical Group Co Ltd
Tiansheng Pharmaceutical Group Co., Ltd. engages in the pharmaceutical manufacturing and circulation activities. It offers products in various categories, including respiratory, cardiovascular and cerebrovascular, urinary system, gynecological, orthopedic, cardiology, diabetes, anesthetic, and others. It also provides traditional Chinese medicines and glucose injection. The company was founded in… Read more